BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29416776)

  • 1. Monoclonal gammopathy of renal significance (MGRS) increases the risk for progression to multiple myeloma: an observational study of 2935 MGUS patients.
    Steiner N; Göbel G; Suchecki P; Prokop W; Neuwirt H; Gunsilius E
    Oncotarget; 2018 Jan; 9(2):2344-2356. PubMed ID: 29416776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal Gammopathy and Its Association with Progression to Kidney Failure and Mortality in Patients with CKD.
    Sy-Go JPT; Moubarak S; Vaughan LE; Klomjit N; Viehman JK; Fervenza FC; Zand L
    Clin J Am Soc Nephrol; 2024 Mar; 19(3):319-328. PubMed ID: 37948069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
    Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicopathological characteristics of patients with paraproteinemia and renal damage.
    Tang X; Wan F; Yu J; Li X; Yang R; Zhu B
    Eur J Med Res; 2021 Jul; 26(1):68. PubMed ID: 34217367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
    Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
    Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.
    Ciocchini M; Arbelbide J; Musso CG
    Int Urol Nephrol; 2017 Dec; 49(12):2171-2175. PubMed ID: 28425076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of monoclonal gammopathy of renal significance.
    Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
    Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.
    Amaador K; Peeters H; Minnema MC; Nguyen TQ; Dendooven A; Vos JMI; Croockewit AJ; van de Donk NWCJ; Jacobs JFM; Wetzels JFM; Sprangers B; Abrahams AC
    Neth J Med; 2019 Sep; 77(7):243-254. PubMed ID: 31582582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation and management of monoclonal gammopathy of renal significance and monoclonal gammopathy of neurological significance.
    Castillo JJ; Callander NS; Baljevic M; Sborov DW; Kumar S
    Am J Hematol; 2021 Jul; 96(7):846-853. PubMed ID: 33709474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study.
    Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
    Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
    López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
    Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort study.
    He H; Wang Z; Xu J; Liu Y; Shao Y; Hou Y; Gu J; Hu R; Xing G
    Sci Rep; 2024 Apr; 14(1):7667. PubMed ID: 38561447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate and Predictors of Finding Monoclonal Gammopathy of Renal Significance (MGRS) Lesions on Kidney Biopsy in Patients with Monoclonal Gammopathy.
    Klomjit N; Leung N; Fervenza F; Sethi S; Zand L
    J Am Soc Nephrol; 2020 Oct; 31(10):2400-2411. PubMed ID: 32747354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal Gammopathies After Renal Transplantation: A Single-center Study.
    Bhasin B; Szabo A; Wu R; Saad ER; Hari P; Dhakal B; Chhabra S; D'Souza A
    Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e468-e473. PubMed ID: 32340914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of immunotactoid glomerulopathy in a patient with monoclonal gammopathy of renal significance.
    Campdesuner V; Teklie Y; Lattanzio N; Lorenzo C; Bell S; Rodriguez Y; Sastry A
    J Community Hosp Intern Med Perspect; 2021 Jan; 11(1):60-64. PubMed ID: 33552417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report.
    Ono E; Ishii A; Higashi Y; Koita N; Ayaki T; Tanigaki K; Takayanagi S; Kondo N; Sakai K; Endo S; Yokoi H; Matsubara T; Minamiguchi S; Nishino I; Takahashi R; Yanagita M
    BMC Nephrol; 2021 Feb; 22(1):74. PubMed ID: 33639890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spectrum of monoclonal gammopathies].
    Matuszkiewicz-Rowińska J; Wieliczko M
    Wiad Lek; 2017; 70(6 pt 2):1170-1174. PubMed ID: 29533907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.